Welcome to our dedicated page for Salesforce Com news (Ticker: CRM), a resource for investors and traders seeking the latest updates and insights on Salesforce Com stock.
News about Salesforce, Inc. (NYSE: CRM) focuses on its activities as an AI-powered enterprise cloud and CRM provider, along with its role in helping organizations become what it calls Agentic Enterprises. Company announcements highlight new AI agents, platform enhancements, customer deployments, acquisitions, and capital allocation decisions that shape how Salesforce technology is used across industries.
Recent releases describe the general availability of a reimagined Slackbot as a personal agent for work inside Slack, designed to use conversational and customer context to help people find information, organize work, create content, and orchestrate workflows. Other news covers deployments of Agentforce 360 and Data 360 at institutions such as DeVry University, where AI agents support adult learners with 24/7 assistance, streamlined enrollment, and personalized guidance.
Salesforce news also details how public sector and life sciences organizations use its platforms. The U.S. Department of Transportation is reported to be expanding its use of Salesforce and Agentforce to modernize complaint management, safety inspections, interstate data sharing, and federal grantmaking. In life sciences, companies such as Novartis and AstraZeneca are described as selecting Agentforce Life Sciences to unify healthcare professional engagement and customer interactions using AI and data harmonization.
In addition, Salesforce publishes Cyber Week commerce data based on aggregated activity across digital storefronts powered by Agentforce Commerce, emphasizing the role of AI and agents in influencing sales and handling customer service interactions. Investors and observers can also find updates on dividends, acquisitions such as the completion of the Informatica transaction, and other corporate developments. This news feed provides an ongoing view into how Salesforce’s AI, data, and cloud capabilities are being adopted and expanded across sectors.
Salesforce (NYSE: CRM) has announced a definitive agreement to acquire Informatica (NYSE: INFA) for $8 billion in equity value. Under the deal, Informatica shareholders will receive $25 per share in cash. The acquisition aims to enhance Salesforce's data foundation for AI deployment by combining Informatica's data catalog, integration, governance, and Master Data Management (MDM) capabilities with Salesforce's platform.
The merger will strengthen Salesforce's position in the $150 billion-plus enterprise data market and create a unified architecture for agentic AI. The integration will enhance key Salesforce products including Data Cloud, Agentforce, Customer 360, MuleSoft, and Tableau. The transaction is expected to close in early fiscal year 2027 and will be funded through cash and new debt. Salesforce expects positive impacts on non-GAAP operating margin, earnings per share, and free cash flow starting in the second year post-closing.
Salesforce (NYSE: CRM) announced that Indeed, the world's leading job site, is implementing Agentforce to enhance employer account onboarding through AI-powered support. Indeed, which connects over 3.3 million employers with candidates from 610 million Job Seeker Profiles, aims to streamline its support operations by automating routine administrative tasks.
The implementation comes after discovering that 22% of employer support requests relate to onboarding or account moderation. Agentforce will autonomously handle common queries about account verification and job posting issues, allowing Indeed's staff to focus on more complex employer relationships. The solution will be integrated with Data Cloud for data harmonization and MuleSoft for accessing third-party data sources, creating a comprehensive support ecosystem.
Salesforce (NYSE:CRM) has announced a strategic partnership with Takeda to implement its Life Sciences Cloud for Customer Engagement platform. Takeda will utilize Salesforce's unified platform, including Agentforce and Data Cloud, to deploy personalized AI agents across medical, commercial, and patient support functions.
As an early adopter, Takeda will have influence in developing Salesforce's Life Sciences Cloud Platform, joining other leading pharmaceutical and biotech companies. The platform aims to unify data and engagement across organizations, providing real-time insights and intelligent analytics directly in workflows to enhance communication with healthcare professionals.
Salesforce (NYSE: CRM) has introduced new flexible pricing for its Agentforce AI platform, addressing the growing demand for digital labor solutions. The company unveiled three major pricing innovations:
1. New Flex Credits: A consumption-based model priced at $500 per 100,000 credits ($0.10 per action), allowing businesses to pay only for actual AI actions performed.
2. Flex Agreement: Enables organizations to strategically shift investments between user licenses and digital labor.
3. New Agentforce User Licenses: Offers unlimited employee-facing agent usage with a per-user monthly pricing model, launching Summer 2025.
The new pricing structure aims to help organizations scale AI adoption while maintaining cost control, as 90% of CIOs report that managing AI costs limits their ability to drive value.
Proof Mark, Inc. (PMI), a Salesforce (NYSE: CRM) partner and shareholder, has issued an open letter to CEO Marc Benioff addressing critical operational and fiduciary concerns. The company has previously raised these issues through four consecutive Red Flag Notices under the Delaware Chancery Court ruling. Salesforce's board has remained silent for over 30 days regarding these notices, raising significant governance concerns.
PMI has launched a dedicated Substack microsite to provide transparency and updates on the situation, including documentation relevant to investors, partners, analysts, and regulators. The company plans to continue publishing additional disclosures and ecosystem governance data to drive awareness and change.